Insider Transactions Reported by 17 Insiders of Evolus, Inc.

Symbol
EOLS on Nasdaq
Location
Newport Beach, CA

Insiders trading volume in the past year

Evolus, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alphaeon 1 LLC 10%+ Owner $35.4M 17 Feb 2023
Medytox Inc. Former 10% Owner $25.4M 16 Oct 2023
SIMONE BLANK Director $6.08M 07 Mar 2025
DAVID MOATAZEDI President & Chief Executive Officer, Director $5.68M -$2.89M -33.7% 13 Jun 2025
Rui Avelar Chief Medical Officer & Head of Research and Development $3.8M -$403K -9.59% 12 May 2025
Vikram Malik Director $2.76M 07 Mar 2025
Sandra Beaver Chief Financial Officer $2.06M -$184K -8.21% 13 May 2025
LAUREN P. SILVERNAIL Chief Financial Officer and Executive Vice President, Corporate Development $1.38M 17 May 2022
Crystal Muilenburg Chief Marketing Officer $1.31M 08 Mar 2022
Tomoko Yamagishi-Dressler Chief Marketing Officer $869K -$103K -10.6% 22 Aug 2025
ROBERT HAYMAN Director $857K 07 Feb 2024
Tatjana Mitchell Chief Financial Officer $642K 08 Sep 2025
Brady Stewart Director $604K +$204K +51.2% 15 Aug 2025
PETER C. FARRELL Director $517K 27 Jan 2023
Albert G. White III Director $476K +$189K +65.8% 09 Jun 2025
DAVID N. GILL Director $448K 07 Mar 2025
Karah Parschauer Director $418K -$167K -28.6% 12 Mar 2025

Recent Insider Transactions by Companies or Individuals for Evolus, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.